145 related articles for article (PubMed ID: 26716649)
1. Simultaneous gene silencing of KRAS and anti-apoptotic genes as a multitarget therapy.
Werner K; Lademann F; Thepkaysone ML; Jahnke B; Aust DE; Kahlert C; Weber G; Weitz J; Grützmann R; Pilarsky C
Oncotarget; 2016 Jan; 7(4):3984-92. PubMed ID: 26716649
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous gene silencing of Bcl-2, XIAP and Survivin re-sensitizes pancreatic cancer cells towards apoptosis.
Rückert F; Samm N; Lehner AK; Saeger HD; Grützmann R; Pilarsky C
BMC Cancer; 2010 Jul; 10():379. PubMed ID: 20646298
[TBL] [Abstract][Full Text] [Related]
3. Fyn requires HnRNPA2B1 and Sam68 to synergistically regulate apoptosis in pancreatic cancer.
Chen ZY; Cai L; Zhu J; Chen M; Chen J; Li ZH; Liu XD; Wang SG; Bie P; Jiang P; Dong JH; Li XW
Carcinogenesis; 2011 Oct; 32(10):1419-26. PubMed ID: 21642356
[TBL] [Abstract][Full Text] [Related]
4. Lentivirus-mediated shRNA targeting XIAP and survivin inhibit SW1990 pancreatic cancer cell proliferation in vitro and in vivo.
Jiang C; Tan T; Yi XP; Shen H; Li YX
Mol Med Rep; 2011; 4(4):667-74. PubMed ID: 21479361
[TBL] [Abstract][Full Text] [Related]
5. A novel small-molecule IAP antagonist, AZD5582, draws Mcl-1 down-regulation for induction of apoptosis through targeting of cIAP1 and XIAP in human pancreatic cancer.
Moon JH; Shin JS; Hong SW; Jung SA; Hwang IY; Kim JH; Choi EK; Ha SH; Kim JS; Kim KM; Hong DW; Kim D; Kim YS; Kim JE; Kim KP; Hong YS; Choi EK; Lee JS; Hattersley M; Jin DH; Kim TW
Oncotarget; 2015 Sep; 6(29):26895-908. PubMed ID: 26314849
[TBL] [Abstract][Full Text] [Related]
6. Targeting XIAP bypasses Bcl-2-mediated resistance to TRAIL and cooperates with TRAIL to suppress pancreatic cancer growth in vitro and in vivo.
Vogler M; Walczak H; Stadel D; Haas TL; Genze F; Jovanovic M; Gschwend JE; Simmet T; Debatin KM; Fulda S
Cancer Res; 2008 Oct; 68(19):7956-65. PubMed ID: 18829553
[TBL] [Abstract][Full Text] [Related]
7. Expression of livin in gastric cancer and induction of apoptosis in SGC-7901 cells by shRNA-mediated silencing of livin gene.
Wang TS; Ding QQ; Guo RH; Shen H; Sun J; Lu KH; You SH; Ge HM; Shu YQ; Liu P
Biomed Pharmacother; 2010 May; 64(5):333-8. PubMed ID: 19914791
[TBL] [Abstract][Full Text] [Related]
8. IFN-γ combined with targeting of XIAP leads to increased apoptosis-sensitisation of TRAIL resistant pancreatic carcinoma cells.
Büneker CK; Yu R; Deedigan L; Mohr A; Zwacka RM
Cancer Lett; 2012 Mar; 316(2):168-77. PubMed ID: 22104728
[TBL] [Abstract][Full Text] [Related]
9. Combined silencing of K-ras and Akt2 oncogenes achieves synergistic effects in inhibiting pancreatic cancer cell growth in vitro and in vivo.
Shi XH; Liang ZY; Ren XY; Liu TH
Cancer Gene Ther; 2009 Mar; 16(3):227-36. PubMed ID: 18949011
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous silencing of XIAP and survivin causes partial mesenchymal-epithelial transition of human pancreatic cancer cells via the PTEN/PI3K/Akt pathway.
Yi XP; Han T; Li YX; Long XY; Li WZ
Mol Med Rep; 2015 Jul; 12(1):601-8. PubMed ID: 25707849
[TBL] [Abstract][Full Text] [Related]
11. Hydroxycamptothecin induces apoptosis and inhibits tumor growth in colon cancer by the downregulation of survivin and XIAP expression.
Fei B; Chi AL; Weng Y
World J Surg Oncol; 2013 May; 11():120. PubMed ID: 23721525
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of cell proliferation and increase of chemosensitivity by simultaneous knockdown of XIAP and survivin in pancreatic carcinoma cells.
Yang J; Ouyang J; Ouyang L; Ouyang L; Chen Y
Oncol Res; 2013; 21(1):43-50. PubMed ID: 24330851
[TBL] [Abstract][Full Text] [Related]
13. Mutated K-ras activates CDK8 to stimulate the epithelial-to-mesenchymal transition in pancreatic cancer in part via the Wnt/β-catenin signaling pathway.
Xu W; Wang Z; Zhang W; Qian K; Li H; Kong D; Li Y; Tang Y
Cancer Lett; 2015 Jan; 356(2 Pt B):613-27. PubMed ID: 25305448
[TBL] [Abstract][Full Text] [Related]
14. Cryptotanshinone potentiates the antitumor effects of doxorubicin on gastric cancer cells via inhibition of STAT3 activity.
Wang J; Zhang G; Dai C; Gao X; Wu J; Shen L; Chen Z; Liu P
J Int Med Res; 2017 Feb; 45(1):220-230. PubMed ID: 28222632
[TBL] [Abstract][Full Text] [Related]
15. Effective suppression of the Kirsten rat sarcoma viral oncogene in pancreatic tumor cells via targeted small interfering RNA delivery using nanoparticles.
Zeng L; Li J; Li J; Zhang Q; Qian C; Wu W; Lin Z; Liang J; Chen Y; Huang K
Pancreas; 2015 Mar; 44(2):250-9. PubMed ID: 25401377
[TBL] [Abstract][Full Text] [Related]
16. KRAS mutational subtype and copy number predict in vitro response of human pancreatic cancer cell lines to MEK inhibition.
Hamidi H; Lu M; Chau K; Anderson L; Fejzo M; Ginther C; Linnartz R; Zubel A; Slamon DJ; Finn RS
Br J Cancer; 2014 Oct; 111(9):1788-801. PubMed ID: 25167228
[TBL] [Abstract][Full Text] [Related]
17. [X-linked inhibitor of apoptosis protein (XIAP) and Survivin suppression on human pancreatic cancer cells Panc-1 proliferation and chemosensitivety].
Zai HY; Yi XP; Li YX; You XY; Cao LP; Liu H
Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 45(2):242-9. PubMed ID: 23591345
[TBL] [Abstract][Full Text] [Related]
18. siRNA-mediated inhibition of antiapoptotic genes enhances chemotherapy efficacy in bladder cancer cells.
Kunze D; Erdmann K; Froehner M; Wirth MP; Fuessel S
Anticancer Res; 2012 Oct; 32(10):4313-8. PubMed ID: 23060552
[TBL] [Abstract][Full Text] [Related]
19. [RNAi-mediated gene silencing of livin synergistic with epirubicin enhance apoptosis of human breast cancer cells].
Liang CY; Ma P; Liu XL
Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(24):1703-6. PubMed ID: 19024543
[TBL] [Abstract][Full Text] [Related]
20. Targeting STAT3 signaling in pancreatic cancer promotes antiapoptotic gene expression.
Glienke W; Hausmann E; Bergmann L
Pancreas; 2011 Mar; 40(2):323-4. PubMed ID: 21311318
[No Abstract] [Full Text] [Related]
[Next] [New Search]
